GREG ZANTE
CIK 1264949 · Chief Financial Officer · last filed 2026-01-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.50M
Companies
3
Total Filings
24
Lifetime Open-Market Net
-$25.77M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VKTX | Chief Financial Officer | 191,371 | $28.75 | $5.50M | -$25.34M | 16 | 2026-01-05 |
| Viking Therapeutics, Inc. (VKTXW) Delisted | Chief Financial Officer | 89,751 | $4.60 | $412.9K | $0 | 2 | 2021-01-19 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | VP, Finance & Administration | 0 | $0.18 | $0 | -$430.0K | 6 | 2008-03-12 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-01-10 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Mixed | — | -$40.4K | EDGAR |
| 2007-12-14 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-12-11 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Mixed | — | -$57.1K | EDGAR |
| 2007-11-13 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Mixed | −642 | -$180.8K | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.